A

Active Director Director DIN 10737910
DIN 10737910 First appointment Aug 2024 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2024
Shareholding value •••• Premium profile

About Amaresh

Data last updated:

Amaresh is a Director at Twinwin Pharmaceuticals India Private Limited (since 2024). The company operates in Pharma. Twinwin Pharmaceuticals India Private Limited reported revenue of ₹14.3 Lakh (FY 2025).

DIN 10737910
Primary Designation Director
Industry Pharma
First Appointment 09 Aug 2024
Oldest Company Age 2 yrs
Largest company Twinwin Pharmaceuticals India Private Limited · ₹14.3 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director09 Aug 20242024₹14.3 Lakh (FY 2025)Active

Board colleagues of Amaresh

NameDINCompanyDesignation
Siddanna10737911Twinwin Pharmaceuticals India Private LimitedDirector

Directorship timeline

Open interactive timeline →
Twinwin Pharmaceuticals India Private Limited
Premium access

Shareholding and investment profile for Amaresh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Amaresh

Amaresh currently holds 1 directorship: Twinwin Pharmaceuticals India Private Limited (Director, since 09 Aug 2024, revenue ₹14.3 Lakh (FY 2025)).

Amaresh was first appointed on 09 Aug 2024 as Director at Twinwin Pharmaceuticals India Private Limited.

The current boards of Amaresh's companies include Siddanna (Twinwin Pharmaceuticals India Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available